FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SEMA3D-KCNU1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SEMA3D-KCNU1
FusionPDB ID: 80285
FusionGDB2.0 ID: 80285
HgeneTgene
Gene symbol

SEMA3D

KCNU1

Gene ID

223117

157855

Gene namesemaphorin 3Dpotassium calcium-activated channel subfamily U member 1
SynonymsSema-Z2|coll-2KCNMC1|KCa5|KCa5.1|Kcnma3|Slo3
Cytomap

7q21.11

8p11.23

Type of geneprotein-codingprotein-coding
Descriptionsemaphorin-3Dcollapsin 2sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Dpotassium channel subfamily U member 1Calcium-activated potassium channel subunit alpha-3Calcium-activated potassium channel, subfamily M subunit alpha-3Slowpoke homolog 3potassium channel, subfamily U, member 1
Modification date2020031320200313
UniProtAcc.

A8MYU2

Main function of 5'-partner protein: FUNCTION: Testis-specific potassium channel activated by both intracellular pH and membrane voltage that mediates export of K(+). May represent the primary spermatozoan K(+) current. In contrast to KCNMA1/SLO1, it is not activated by Ca(2+) or Mg(2+). Critical for fertility. May play an important role in sperm osmoregulation required for the acquisition of normal morphology and motility when faced with osmotic challenges, such as those experienced after mixing with seminal fluid and entry into the vagina. {ECO:0000269|PubMed:23129643}.
Ensembl transtripts involved in fusion geneENST idsENST00000284136, ENST00000444867, 
ENST00000484038, 
ENST00000518904, 
ENST00000399881, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 6 X 3=908 X 7 X 7=392
# samples 511
** MAII scorelog2(5/90*10)=-0.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(11/392*10)=-1.83335013059055
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SEMA3D [Title/Abstract] AND KCNU1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SEMA3D [Title/Abstract] AND KCNU1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SEMA3D(84751057)-KCNU1(36721922), # samples:1
SEMA3D(84727121)-KCNU1(36721922), # samples:1
Anticipated loss of major functional domain due to fusion event.SEMA3D-KCNU1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SEMA3D-KCNU1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SEMA3D-KCNU1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SEMA3D-KCNU1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SEMA3D-KCNU1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:84751057/chr8:36721922)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SEMA3D (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KCNU1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000444867SEMA3Dchr784751057-ENST00000399881KCNU1chr836721922+22685013262059577

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000444867ENST00000399881SEMA3Dchr784751057-KCNU1chr836721922+0.0035361950.99646384

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SEMA3D-KCNU1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SEMA3Dchr784751057KCNU1chr83672192250158LKQNIPRLKLTYKVPSVKRMKKCLKG

Top

Potential FusionNeoAntigen Information of SEMA3D-KCNU1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SEMA3D-KCNU1_84751057_36721922.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SEMA3D-KCNU1chr784751057chr836721922501HLA-B52:01LTYKVPSV0.99240.9783917
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:08LTYKVPSVK0.99590.741918
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:13KLTYKVPSV0.99360.7185817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:22KLTYKVPSV0.99340.5538817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:11KLTYKVPSV0.99270.6605817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:60KLTYKVPSV0.99220.5874817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:24KLTYKVPSV0.99190.643817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:67KLTYKVPSV0.99190.643817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:30KLTYKVPSV0.99190.643817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:27KLTYKVPSV0.99050.6821817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A11:03KVPSVKRMK0.98990.53241221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:16KLTYKVPSV0.98990.6035817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:21KLTYKVPSV0.98970.7545817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:04KLTYKVPSV0.98830.6357817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:08KVPSVKRMK0.98660.7381221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:38KLTYKVPSV0.9840.705817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:11LTYKVPSVK0.97770.5306918
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:09LTYKVPSVK0.97770.5306918
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:03LTYKVPSVK0.97770.5306918
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:02TYKVPSVKR0.88850.68261019
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:11KVPSVKRMK0.87870.55521221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:03KVPSVKRMK0.87870.55521221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:09KVPSVKRMK0.87870.55521221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:29KLTYKVPSV0.86860.6471817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:35KLTYKVPSV0.86240.6593817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:20KLTYKVPSV0.85190.6447817
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:18YKVPSVKRM0.60640.80731120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:03YKVPSVKRM0.57360.8381120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:10YKVPSVKRM0.5240.64751120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:37YKVPSVKRM0.24540.62571120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B13:02KLTYKVPSV0.06080.7824817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:08KVPSVKRMKK0.99520.7321222
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:09LTYKVPSVKR0.98830.7521919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:03LTYKVPSVKR0.98830.7521919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:11LTYKVPSVKR0.98830.7521919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:08KLTYKVPSVK0.97710.7058818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:06LTYKVPSVKR0.97610.5463919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:02LTYKVPSVKR0.96280.7448919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:11KLTYKVPSVK0.84460.5914818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:03KLTYKVPSVK0.84460.5914818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:09KLTYKVPSVK0.84460.5914818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:11KLTYKVPSVKR0.97190.7861819
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:03KLTYKVPSVKR0.97190.7861819
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:09KLTYKVPSVKR0.97190.7861819
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:06KLTYKVPSVKR0.95980.5368819
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:02KLTYKVPSVKR0.95690.7783819
SEMA3D-KCNU1chr784751057chr836721922501HLA-B51:07LTYKVPSV0.99210.9737917
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:07KLTYKVPSV0.99220.6818817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:01KLTYKVPSV0.99190.643817
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:95YKVPSVKRM0.99090.73671120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A11:01KVPSVKRMK0.98610.50981221
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:27YKVPSVKRM0.98550.9491120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:05YKVPSVKRM0.96220.94531120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:01TYKVPSVKR0.95610.64851019
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:29YKVPSVKRM0.9540.93421120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:46YKVPSVKRM0.88990.89951120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:13YKVPSVKRM0.84780.92811120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:19YKVPSVKRM0.80110.79171120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:67YKVPSVKRM0.79480.94991120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:80YKVPSVKRM0.79480.94991120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:10YKVPSVKRM0.79440.95781120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C12:12YKVPSVKRM0.03240.93381120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C12:16YKVPSVKRM0.02040.97111120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C12:04YKVPSVKRM0.00680.99481120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C06:03YKVPSVKRM0.00640.99341120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:01LTYKVPSVKR0.98890.7172919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A31:01KLTYKVPSVKR0.97840.7558819
SEMA3D-KCNU1chr784751057chr836721922501HLA-C15:02LTYKVPSV0.99990.8692917
SEMA3D-KCNU1chr784751057chr836721922501HLA-B51:21LTYKVPSV0.9930.5471917
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:03KLTYKVPSV0.99690.7205817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:01LTYKVPSVK0.99590.8503918
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:01YKVPSVKRM0.99410.72591120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:14KLTYKVPSV0.990.641817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A02:06KLTYKVPSV0.98970.7545817
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:01KVPSVKRMK0.98710.79191221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A11:02KVPSVKRMK0.98610.50981221
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:01LTYKVPSVK0.97770.5306918
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:17YKVPSVKRM0.93020.961120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:01KVPSVKRMK0.87870.55521221
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:02YKVPSVKRM0.79480.94991120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:22YKVPSVKRM0.72040.70331120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B48:02YKVPSVKRM0.55920.93651120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C06:08YKVPSVKRM0.51720.99371120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:09YKVPSVKRM0.34780.59581120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C03:67YKVPSVKRM0.26290.97971120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C07:04KLTYKVPSV0.19410.9164817
SEMA3D-KCNU1chr784751057chr836721922501HLA-C12:03YKVPSVKRM0.04930.98371120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C06:06YKVPSVKRM0.04340.9921120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:68YKVPSVKRM0.02620.63291120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C12:02YKVPSVKRM0.02370.97491120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C06:02YKVPSVKRM0.01360.99421120
SEMA3D-KCNU1chr784751057chr836721922501HLA-C06:17YKVPSVKRM0.01360.99421120
SEMA3D-KCNU1chr784751057chr836721922501HLA-B15:54YKVPSVKRM0.0120.89781120
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:01KVPSVKRMKK0.99550.78471222
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:01LTYKVPSVKR0.98830.7521919
SEMA3D-KCNU1chr784751057chr836721922501HLA-A30:01KLTYKVPSVK0.97830.8377818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:01KLTYKVPSVK0.84460.5914818
SEMA3D-KCNU1chr784751057chr836721922501HLA-A74:01KLTYKVPSVKR0.97190.7861819

Top

Potential FusionNeoAntigen Information of SEMA3D-KCNU1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SEMA3D-KCNU1_84751057_36721922.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0804IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0820IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0820NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0828IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0831IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-0831NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1104IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1104NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1106IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1106NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1117IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1118IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1125IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1127IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1135IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1135NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1137IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1138IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1138NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1141IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1142IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1143IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1143NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1144IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1144NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1146IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1146NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1147IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1147NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1150IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1150NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1152IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1153IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1154IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1154NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1156IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1156NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1157IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1158IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1158NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1160IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1160NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1167IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1172IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1177IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1177NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1178IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1178NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1180IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1183IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1183NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1184IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1184NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1187IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1188IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1188NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1189IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1189NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1192IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1193IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1306IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1307IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1311IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1311NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1318IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1326IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1342IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1342NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1385IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1403IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1405IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1406IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1408IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1411IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1412IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1414IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1415IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1418IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1418NIPRLKLTYKVPSVK318
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1420IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1423IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1427IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1429IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1433IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1434IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1436IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1440IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1443IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1444IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1445IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1451IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1456IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1459IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1464IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1467IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1472IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1473IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1477IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1480IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1481IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1483IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1484IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1491IPRLKLTYKVPSVKR419
SEMA3D-KCNU1chr784751057chr836721922501DRB1-1496IPRLKLTYKVPSVKR419

Top

Fusion breakpoint peptide structures of SEMA3D-KCNU1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8012RLKLTYKVPSVKRMSEMA3DKCNU1chr784751057chr836721922501

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SEMA3D-KCNU1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8012RLKLTYKVPSVKRM-7.15543-7.26883
HLA-B14:023BVN8012RLKLTYKVPSVKRM-4.77435-5.80965
HLA-B52:013W398012RLKLTYKVPSVKRM-6.80875-6.92215
HLA-B52:013W398012RLKLTYKVPSVKRM-4.20386-5.23916
HLA-A11:014UQ28012RLKLTYKVPSVKRM-7.5194-8.5547
HLA-A11:014UQ28012RLKLTYKVPSVKRM-6.9601-7.0735
HLA-A24:025HGA8012RLKLTYKVPSVKRM-7.52403-7.63743
HLA-A24:025HGA8012RLKLTYKVPSVKRM-5.82433-6.85963
HLA-B27:056PYJ8012RLKLTYKVPSVKRM-3.28285-4.31815
HLA-B44:053DX88012RLKLTYKVPSVKRM-5.91172-6.94702
HLA-B44:053DX88012RLKLTYKVPSVKRM-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of SEMA3D-KCNU1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SEMA3D-KCNU1chr784751057chr8367219221019TYKVPSVKRCCTACAAAGTGCCATCGGTAAAGAGAA
SEMA3D-KCNU1chr784751057chr8367219221120YKVPSVKRMACAAAGTGCCATCGGTAAAGAGAATGA
SEMA3D-KCNU1chr784751057chr8367219221221KVPSVKRMKAAGTGCCATCGGTAAAGAGAATGAAAA
SEMA3D-KCNU1chr784751057chr8367219221222KVPSVKRMKKAAGTGCCATCGGTAAAGAGAATGAAAAAAT
SEMA3D-KCNU1chr784751057chr836721922817KLTYKVPSVAGCTAACCTACAAAGTGCCATCGGTAA
SEMA3D-KCNU1chr784751057chr836721922818KLTYKVPSVKAGCTAACCTACAAAGTGCCATCGGTAAAGA
SEMA3D-KCNU1chr784751057chr836721922819KLTYKVPSVKRAGCTAACCTACAAAGTGCCATCGGTAAAGAGAA
SEMA3D-KCNU1chr784751057chr836721922917LTYKVPSVTAACCTACAAAGTGCCATCGGTAA
SEMA3D-KCNU1chr784751057chr836721922918LTYKVPSVKTAACCTACAAAGTGCCATCGGTAAAGA
SEMA3D-KCNU1chr784751057chr836721922919LTYKVPSVKRTAACCTACAAAGTGCCATCGGTAAAGAGAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SEMA3D-KCNU1chr784751057chr836721922318NIPRLKLTYKVPSVKATATTCCAAGACTCAAGCTAACCTACAAAGTGCCATCGGTAAAGA
SEMA3D-KCNU1chr784751057chr836721922419IPRLKLTYKVPSVKRTTCCAAGACTCAAGCTAACCTACAAAGTGCCATCGGTAAAGAGAA

Top

Information of the samples that have these potential fusion neoantigens of SEMA3D-KCNU1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUSCSEMA3D-KCNU1chr784751057ENST00000444867chr836721922ENST00000399881TCGA-77-A5G7-01B

Top

Potential target of CAR-T therapy development for SEMA3D-KCNU1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SEMA3D-KCNU1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SEMA3D-KCNU1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource